Mitral valve prolapse: Old beliefs yield to new knowledge

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 11, 2002, Pages 889-896

  Hayek, Emil ^a   Griffin, Brian ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; WARFARIN;

ARTICLE; BACTERIAL ENDOCARDITIS; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HEART ARRHYTHMIA; HEART AUSCULTATION; HEART DEATH; HUMAN; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PREVALENCE; PROGNOSIS; SENSITIVITY ANALYSIS; STROKE; SUDDEN DEATH; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0036851011     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.11.889     Document Type: Article

References (54)

1. Barlow JB, Bosman CK. Aneurysmal protrusion of the posterior leaflet of the mitral valve: an auscultatory-electrocardiographic syndrome. Am Heart J 1966; 71:166-178.
2. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341:1-7.
3. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population, I: epidemiologic features-the Framingham Study. Am Heart J 1983; 106:571-576.
4. Barber JE, Kasper FK, Ratliff NB, Cosgrove DM, Griffin BP, Vesely I. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg 2001; 122:955-962.
5. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med 1982; 97:826-832.
6. Attenhofer Jost CH, Turina J, Mayer K, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med 2000; 108:614-620.
7. Weis AJ, Salcedo EE, Stewart WJ, Lever HM, Klein AL, Thomas JD. Anatomic explanation of mobile systolic clicks: implications for the clinical and echocardiographic diagnosis of mitral valve prolapse. Am Heart J 1995; 129:314-320.
8. Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277:564-571.
9. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98:672-707.
10. Levine RA, Handschumacher MD, Sanfilippo AJ, et al. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation 1989; 80:589-598.
11. Devereux RB, Kramer-Fox R, Brown WT, et al. Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse. J Am Coll Cardiol 1986; 8:763-772.
12. Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population, II: clinical features-the Framingham Study. Am Heart J 1983; 106:577-581.
13. Retchin SM, Fletcher RH, Earp J, Lamson N, Waugh RA. Mitral valve prolapse: disease or illness? Arch Intern Med 1986; 146:1081-1084.
14. Bhutto ZR, Barron JT, Liebson PR, Uretz EF, Parrillo JE. Electrocardiographic abnormalities in mitral valve prolapse. Am J Cardiol 1992; 70:265-266.
15. Gaffney FA, Karlsson ES, Campbell W, et al. Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 1979; 59:894-901.
16. Puddu PE, Pasternac A, Tubau JF, Krol R, Farley L, de Champlain J. QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J 1983; 105:422-428.
17. Pasternac A, Tubau JF, Puddu PE, Krol RB, de Champlain J. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 1982; 73:783-790.
18. Gaffney FA, Bastian BC, Lane LB, et al. Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol 1983; 52:316-320.
19. Anwar A, Kohn SR, Dunn JF, et al. Altered beta adrenergic receptor function in subjects with symptomatic mitral valve prolapse. Am J Med Sci 1991; 302:89-97.
20. Chesler E, Weir EK, Braatz GA, Francis GS. Normal catecholamine and hemodynamic responses to orthostatic tilt in subjects with mitral valve prolapse: correlation with psychologic testing. Am J Med 1985; 78:754-760.
21. Lenders JW, Fast JH, Blankers J, de Boo T, Lemmens WA, Thien T. Normal sympathetic neural activity in patients with mitral valve prolapse. Clin Cardiol 1986; 9:177-182.
22. Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse: long-term follow-up of 237 patients. N Engl J Med 1985; 313:1305-1309.
23. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol 1995; 75:1028-1032.
24. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse: disproportionate occurrence in men and older patients. Am J Med 1986; 81:751-758.
25. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989; 320:1031-1036.
26. Kamei F, Nakahara N, Yuda S, Kobayashi N, Tsuchihashi K, Shimamoto K. Long-term site-related differences in the progression and regression of the idiopathic mitral valve prolapse syndrome. Cardiology 1999; 91:161-168.
27. Kim S, Kuroda T, Nishinaga M, et al. Relationship between severity of mitral regurgitation and prognosis of mitral valve prolapse: echocardiographic follow-up study. Am Heart J 1996; 132:348-355.
28. MacMahon SW, Roberts JK, Kramer-Fox R, Zucker DM, Roberts RB, Devereux RB. Mitral valve prolapse and infective endocarditis. Am Heart J 1987; 113:1291-1298.
29. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med 1982; 307:776-781.
30. MacMahon SW, Hickey AJ, Wilcken DE, Wittes JT, Feneley MP, Hickie JB. Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol 1987; 59:105-108.
31. Frary CJ, Devereux RB, Kramer-Fox R, Roberts RB, Ruchlin HS. Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse. Am J Cardiol 1994; 73:263-267.
32. Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980; 302:139-144.
33. Kelley RE, Pina I, Lee SC. Cerebral ischemia and mitral valve prolapse: case-control study of associated factors. Stroke 1988; 19:443-446.
34. Jones HR Jr, Naggar CZ, Seljan MP, Downing LL. Mitral valve prolapse and cerebral ischemic events: a comparison between a neurology population with stroke and a cardiology population with mitral valve prolapse observed for five years. Stroke 1982; 13:451-453.
35. Sandok BA, Giuliani ER. Cerebral ischemic events in patients with mitral valve prolapse. Stroke 1982; 13:448-450.
36. Giovannoni G, Fritz VU. Transient ischemic attacks in younger and older patients: a comparative study of 798 patients in South Africa. Stroke 1993; 24:947-953.
37. Gross CM, Nichols FT, von Dohlen TW, D'Cruz IA. Mitral valve prolapse and stroke: echocardiographic evidence for a missing causative link. J Am Soc Echocardiogr 1989; 2:94-97.
38. Petty GW, Orencia AJ, Khandheria BK, Whisnant JP. A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification. Mayo Clin Proc 1994; 69:632-634.
39. Orencia AJ, Petty GW, Khandheria BK, et al. Risk of stroke with mitral valve prolapse in population-based cohort study. Stroke 1995; 26:7-13.
40. Gilon D, Buonanno FS, Joffe MM, et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999; 341:8-13.
41. Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J 1982; 104:276-288.
42. Hickey AJ, Wilcken DE, Wright JS, Warren BA. Primary (spontaneous) chordal rupture: relation to myxomatous valve disease and mitral valve prolapse. J Am Coll Cardiol 1985; 5:1341-1346.
43. Wilcken DE, Hickey AJ. Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery. Circulation 1988; 78:10-14.
44. Singh RG, Cappucci R, Kramer-Fox R, et al. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. Am J Cardiol 2000; 85:193-198.
45. Jeresaty RM, Edwards JE, Chawla SK. Mitral valve prolapse and ruptured chordae tendineae. Am J Cardiol 1985; 55:138-142.
46. Savage DD, Levy D, Garrison RJ, et al. Mitral valve prolapse in the general population, III: dysrhythmias-the Framingham Study. Am Heart J 1983; 106:582-586.
47. Kligfield P, Hochreiter C, Kramer H, et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol 1985; 55:1545-1549.
48. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997; 80:10F-19F.
49. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113:1298-1307.
50. Winkle RA, Lopes MG, Goodman DJ, Fitzgerald JW, Schroeder JS, Harrison DC. Propranolol for patients with mitral valve prolapse. Am Heart J 1977; 93:422-427.
51. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol 1994; 74:1024-1029.
52. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277:1794-1801.
53. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998; 116:734-743.
54. David TE, Omran A, Armstrong S, Sun Z, Ivanov J. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg 1998; 115:1279-1285.